Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atea Pharmaceuticals Inc (NQ: AVIR )

7.140 -0.240 (-3.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 824,369
Open 7.110
Bid (Size) 6.110 (1)
Ask (Size) 7.550 (1)
Prev. Close 7.380
Today's Range 7.000 - 7.480
52wk Range 5.310 - 46.91
Shares Outstanding 83,257,591
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Short Volatility Alert: Atea Pharmaceuticals
On Tuesday, shares of Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) experienced volatile short activity. After the activity, the stock price went down -1.73% to $7.38. The... 
Via Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga

Performance

YTD
-22.31%
-22.31%
1 Month
+15.16%
+15.16%
3 Month
+12.26%
+12.26%
6 Month
-17.84%
-17.84%
1 Year
-69.53%
-69.53%

More News

Read More
Atea Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
Earnings Preview For Atea Pharmaceuticals
Via Benzinga
Earnings Scheduled For February 28, 2022
Via Benzinga
Expert Ratings For Atea Pharmaceuticals
Via Benzinga
How To Attend Atea Pharmaceuticals Q1 2022 Earnings Conference Call
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
NASDAQ:AVIR Investor Notice: Investigation over Potential Wrongdoing at Atea Pharmaceuticals, Inc.
Via SBWire
30 Stocks Moving in Tuesday's Pre-Market Session
Via Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
27 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
Atea Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
Can Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes
Via Investor's Business Daily
NASDAQ:AVIR Investor Notice: Investigation over Possible Securities Laws Violations by Atea Pharmaceuticals, Inc.
Via SBWire
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Atea Pharmaceuticals, Inc. (AVIR) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
Via Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
Via InvestorPlace
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
Via Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
What 5 Analyst Ratings Have To Say About Atea Pharmaceuticals
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.